CA2560995A1 - Formes galeniques pharmaceutiques a liberation immediate et/ou controlee renfermant un agoniste du recepteur gaba<sb>b</sb> - Google Patents
Formes galeniques pharmaceutiques a liberation immediate et/ou controlee renfermant un agoniste du recepteur gaba<sb>b</sb> Download PDFInfo
- Publication number
- CA2560995A1 CA2560995A1 CA002560995A CA2560995A CA2560995A1 CA 2560995 A1 CA2560995 A1 CA 2560995A1 CA 002560995 A CA002560995 A CA 002560995A CA 2560995 A CA2560995 A CA 2560995A CA 2560995 A1 CA2560995 A1 CA 2560995A1
- Authority
- CA
- Canada
- Prior art keywords
- dosage form
- pharmaceutical dosage
- hours
- baclofen
- gaba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/815,929 US20050220864A1 (en) | 2004-04-02 | 2004-04-02 | Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist |
US10/815,924 US20050220863A1 (en) | 2004-04-02 | 2004-04-02 | Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist |
US10/815,926 US20050220873A1 (en) | 2004-04-02 | 2004-04-02 | Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist |
US10/815,924 | 2004-04-02 | ||
US10/815,926 | 2004-04-02 | ||
US10/815,930 | 2004-04-02 | ||
US10/815,930 US20050220874A1 (en) | 2004-04-02 | 2004-04-02 | Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist |
US10/815,929 | 2004-04-02 | ||
PCT/US2005/011032 WO2005097079A2 (fr) | 2004-04-02 | 2005-04-01 | Formes galeniques pharmaceutiques a liberation immediate et/ou controlee renfermant un agoniste du recepteur gabab |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2560995A1 true CA2560995A1 (fr) | 2005-10-20 |
Family
ID=35060819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002560995A Abandoned CA2560995A1 (fr) | 2004-04-02 | 2005-04-01 | Formes galeniques pharmaceutiques a liberation immediate et/ou controlee renfermant un agoniste du recepteur gaba<sb>b</sb> |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1729740A2 (fr) |
JP (1) | JP2007531727A (fr) |
KR (1) | KR20070020022A (fr) |
AU (1) | AU2005231433A1 (fr) |
BR (1) | BRPI0509399A (fr) |
CA (1) | CA2560995A1 (fr) |
IL (1) | IL178296A0 (fr) |
MX (1) | MXPA06011322A (fr) |
NO (1) | NO20065013L (fr) |
TW (1) | TW200536523A (fr) |
WO (1) | WO2005097079A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2672884C1 (ru) * | 2017-11-07 | 2018-11-20 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский государственный педагогический университет им. А.И. Герцена" (РГПУ им. А.И. Герцена) | Средство, сохраняющее популяцию ГАМК-ергических нейронов после острой перинатальной гипоксии |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008086492A1 (fr) * | 2007-01-11 | 2008-07-17 | Xenoport, Inc. | Formes galéniques orales à libération prolongée d'un promédicament de r-baclofène et procédés de traitement |
WO2009096985A1 (fr) * | 2008-02-01 | 2009-08-06 | Xenoport, Inc. | Formes posologiques orales particulaires à libération soustenue de promédicaments de (r)-baclofène et procédés de traitement correspondants |
EP2403486A1 (fr) | 2009-03-03 | 2012-01-11 | XenoPort, Inc. | Formes posologiques orales à libération entretenue d'un promédicament de r-baclofène |
JP7138666B2 (ja) * | 2018-01-24 | 2022-09-16 | 大原薬品工業株式会社 | γ-アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法 |
CN115919806A (zh) * | 2022-12-22 | 2023-04-07 | 南京乐韬生物科技有限公司 | 一种gaba缓释胶囊的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9308430D0 (en) * | 1993-04-23 | 1993-06-09 | Glaxo Group Ltd | Medicaments |
SK6192003A3 (en) * | 2000-11-30 | 2004-07-07 | Pfizer Prod Inc | Combination of GABA agonists and sorbitol dehydrogenase inhibitors |
-
2005
- 2005-04-01 WO PCT/US2005/011032 patent/WO2005097079A2/fr active Application Filing
- 2005-04-01 AU AU2005231433A patent/AU2005231433A1/en not_active Abandoned
- 2005-04-01 BR BRPI0509399-6A patent/BRPI0509399A/pt not_active IP Right Cessation
- 2005-04-01 MX MXPA06011322A patent/MXPA06011322A/es unknown
- 2005-04-01 EP EP05733181A patent/EP1729740A2/fr not_active Withdrawn
- 2005-04-01 JP JP2007506301A patent/JP2007531727A/ja not_active Withdrawn
- 2005-04-01 KR KR1020067022957A patent/KR20070020022A/ko not_active Application Discontinuation
- 2005-04-01 CA CA002560995A patent/CA2560995A1/fr not_active Abandoned
- 2005-04-04 TW TW094110754A patent/TW200536523A/zh unknown
-
2006
- 2006-09-26 IL IL178296A patent/IL178296A0/en unknown
- 2006-11-01 NO NO20065013A patent/NO20065013L/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2672884C1 (ru) * | 2017-11-07 | 2018-11-20 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский государственный педагогический университет им. А.И. Герцена" (РГПУ им. А.И. Герцена) | Средство, сохраняющее популяцию ГАМК-ергических нейронов после острой перинатальной гипоксии |
Also Published As
Publication number | Publication date |
---|---|
JP2007531727A (ja) | 2007-11-08 |
MXPA06011322A (es) | 2007-02-21 |
KR20070020022A (ko) | 2007-02-16 |
WO2005097079A3 (fr) | 2006-01-05 |
EP1729740A2 (fr) | 2006-12-13 |
IL178296A0 (en) | 2007-02-11 |
TW200536523A (en) | 2005-11-16 |
AU2005231433A1 (en) | 2005-10-20 |
NO20065013L (no) | 2007-01-02 |
WO2005097079A2 (fr) | 2005-10-20 |
BRPI0509399A (pt) | 2007-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11147772B2 (en) | Timed, pulsatile release systems | |
EP1940361B1 (fr) | Formes de dosage pharmaceutique possedant des proprietes de liberation controlee et/ou immediate | |
US20050226927A1 (en) | Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist | |
AU2002330211B2 (en) | Timed, sustained release multi-particulate dosage forms of propranolol | |
AU2009247921B2 (en) | Solid oral form with dual release profile, containing multiparticulates | |
CA2560995A1 (fr) | Formes galeniques pharmaceutiques a liberation immediate et/ou controlee renfermant un agoniste du recepteur gaba<sb>b</sb> | |
US20050220873A1 (en) | Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist | |
ZA200608190B (en) | Controleld release dosage for GABA receptor antagonist | |
CN101001612A (zh) | 用于γ-氨基丁酸受体激动剂的控制释放剂型 | |
US20050220864A1 (en) | Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist | |
AU2013273835B2 (en) | Timed, pulsatile release systems | |
MX2008004282A (en) | Pharmaceutical dosage forms having immediate release and/orcontrolled release properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |